secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxcyte, Inc. (PCVX)
CIK:        0001649094
Form:       8-K
Filed at:   2025-12-19T23:59:59+00:00
Accession:  0001649094-25-000116
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxcyte boosts severance multipliers for CEO Pickering and three other execs effective Dec 31, 2025
--------------------------------------------------------------------------------

- CEO Pickering: base salary severance multiplier for Qualifying Termination increases to 1.5x (from 1.0x); CIC termination to 2.0x (from 1.5x).
- CFO Guggenhime, COO Wassil, CTOO Dhaliwal: non-CIC multiplier rises to 1.0x (from 0.75x/0.5x); CIC to 1.5x (from 1.0x/0.75x).
- COBRA severance multipliers increased proportionally across all four executives.
- Changes effective Dec 31, 2025, approved by Compensation Committee to align with peer group levels.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649094/000164909425000116/0001649094-25-000116-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649094/000164909425000116/pcvx-20251218.htm
  HTML page:      https://secwatch.observer/filing/0001649094-25-000116

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer